Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Ovarian Neoplasms 2 Colorectal Neoplasms 2 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Neoplasms 1 Fallopian Tube Neoplasms 1 Carcinoma, Ovarian Epithelial 1 Breast Neoplasms 1

Interventions

Gemcitabine 679 130-nm albumin-bound paclitaxel 198 Fluorouracil 186 Oxaliplatin 175 Albumin-Bound Paclitaxel 151 Capecitabine 137 Leucovorin 131 Irinotecan 113 Radiotherapy 95 Taxes 83 pembrolizumab 80 Cisplatin 72 Erlotinib Hydrochloride 69 Radiosurgery 67 Nivolumab 56 Bevacizumab 54 Drug Therapy 52 Cyclophosphamide 49 Magnetic Resonance Spectroscopy 46 folfirinox 42 Docetaxel 41 Cetuximab 40 Specimen Handling 37 irinotecan sucrosofate 36 S 1 (combination) 36 Biopsy 31 Radiation 29 Paclitaxel 29 Ipilimumab 27 durvalumab 26

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Pancreatic Neoplasms × Etodolac × Clear all

NCT03838029 2019-11-20

BC-PC

Assaf-Harofeh Medical Center

Phase 2 Unknown

Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡